Sinopharm Group Co. Ltd. (HKG:1099)
Hong Kong · Delayed Price · Currency is HKD 19.73
+0.29 (1.49%)
Jan 2, 2026, 4:08 PM HKT
Sinopharm Group Market Cap
Sinopharm Group has a market cap or net worth of 61.57 billion as of January 2, 2026. Its market cap has decreased by -3.99% in one year.
Market Cap
61.57B
Enterprise Value
164.76B
Revenue
626.85B
Ranking
n/a
PE Ratio
7.96
Stock Price
19.73
Market Cap Chart
Since September 23, 2009, Sinopharm Group's market cap has increased from 40.42B to 61.57B, an increase of 52.31%. That is a compound annual growth rate of 2.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 60.67B | -8.73% |
| Dec 31, 2024 | 66.47B | 4.16% |
| Dec 29, 2023 | 63.82B | 3.07% |
| Dec 30, 2022 | 61.91B | 16.98% |
| Dec 31, 2021 | 52.93B | -10.07% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 261.67B |
| Hansoh Pharmaceutical Group Company | 218.43B |
| JD Health International | 178.11B |
| Innovent Biologics | 131.21B |
| WuXi Biologics | 129.79B |
| Sino Biopharmaceutical | 110.48B |
| Akeso | 104.09B |
| CSPC Pharmaceutical Group | 96.38B |